A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271

NCT02724085 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
57
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tetraphase Pharmaceuticals, Inc

Collaborators